CN101721530B - 金鸡制剂的检测方法 - Google Patents
金鸡制剂的检测方法 Download PDFInfo
- Publication number
- CN101721530B CN101721530B CN2009101145670A CN200910114567A CN101721530B CN 101721530 B CN101721530 B CN 101721530B CN 2009101145670 A CN2009101145670 A CN 2009101145670A CN 200910114567 A CN200910114567 A CN 200910114567A CN 101721530 B CN101721530 B CN 101721530B
- Authority
- CN
- China
- Prior art keywords
- reference substance
- dehydro
- drographolide
- andrographolide
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 72
- 238000000034 method Methods 0.000 title claims abstract description 63
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 138
- 239000013558 reference substance Substances 0.000 claims description 105
- BOJKULTULYSRAS-OTESTREVSA-N Andrographolide Chemical compound C([C@H]1[C@]2(C)CC[C@@H](O)[C@]([C@H]2CCC1=C)(CO)C)\C=C1/[C@H](O)COC1=O BOJKULTULYSRAS-OTESTREVSA-N 0.000 claims description 61
- ASLUCFFROXVMFL-UHFFFAOYSA-N andrographolide Natural products CC1(CO)C(O)CCC2(C)C(CC=C3/C(O)OCC3=O)C(=C)CCC12 ASLUCFFROXVMFL-UHFFFAOYSA-N 0.000 claims description 61
- 238000012360 testing method Methods 0.000 claims description 53
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 40
- 239000007788 liquid Substances 0.000 claims description 27
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 20
- 239000000377 silicon dioxide Substances 0.000 claims description 20
- 238000011003 system suitability test Methods 0.000 claims description 19
- 238000001514 detection method Methods 0.000 claims description 18
- 239000000945 filler Substances 0.000 claims description 18
- 239000000706 filtrate Substances 0.000 claims description 18
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 claims description 17
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 15
- 230000007935 neutral effect Effects 0.000 claims description 15
- 238000005303 weighing Methods 0.000 claims description 12
- 239000003480 eluent Substances 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 8
- 238000004811 liquid chromatography Methods 0.000 claims 1
- 238000004128 high performance liquid chromatography Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 100
- QUCQEUCGKKTEBI-UHFFFAOYSA-N palmatine Chemical compound COC1=CC=C2C=C(C3=C(C=C(C(=C3)OC)OC)CC3)[N+]3=CC2=C1OC QUCQEUCGKKTEBI-UHFFFAOYSA-N 0.000 description 56
- VKJGBAJNNALVAV-UHFFFAOYSA-M Berberine chloride (TN) Chemical compound [Cl-].C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 VKJGBAJNNALVAV-UHFFFAOYSA-M 0.000 description 49
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 48
- 239000011259 mixed solution Substances 0.000 description 37
- 238000003556 assay Methods 0.000 description 22
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 20
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 18
- WITLAWYGGVAFLU-UHFFFAOYSA-N 3-(6-methoxy-1,3-benzodioxol-5-yl)-8,8-dimethylpyrano[2,3-f]chromen-4-one Chemical compound C1=CC(C)(C)OC2=CC=C(C(C(C3=CC=4OCOC=4C=C3OC)=CO3)=O)C3=C21 WITLAWYGGVAFLU-UHFFFAOYSA-N 0.000 description 16
- 239000000523 sample Substances 0.000 description 16
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 10
- 239000012488 sample solution Substances 0.000 description 10
- 238000002156 mixing Methods 0.000 description 9
- 238000002791 soaking Methods 0.000 description 9
- PTPHDVKWAYIFRX-UHFFFAOYSA-N Palmatine Natural products C1C2=C(OC)C(OC)=CC=C2C=C2N1CCC1=C2C=C(OC)C(OC)=C1 PTPHDVKWAYIFRX-UHFFFAOYSA-N 0.000 description 8
- 238000011084 recovery Methods 0.000 description 8
- 239000008057 potassium phosphate buffer Substances 0.000 description 7
- 241000736253 Berberis bealei Species 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 241000288027 Chrysolophus pictus Species 0.000 description 5
- 239000012846 chemical reference substance Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000003908 quality control method Methods 0.000 description 5
- 239000000872 buffer Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000007937 lozenge Substances 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- YGCYRQKJYWQXHG-RDNQFMDVSA-N 4-[2-[(1r,4as,5r,8as)-5,8a-dimethyl-2-methylidene-5-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-3,4,4a,6,7,8-hexahydro-1h-naphthalen-1-yl]ethyl]-2h-furan-5-one Chemical compound C([C@@]1(C)[C@H]2CCC(=C)[C@@H](CCC=3C(OCC=3)=O)[C@]2(C)CCC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YGCYRQKJYWQXHG-RDNQFMDVSA-N 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- MXTLAHSTUOXGQF-UHFFFAOYSA-O Jatrorrhizine Chemical compound COC1=CC=C2C=C3C(C=C(C(=C4)O)OC)=C4CC[N+]3=CC2=C1OC MXTLAHSTUOXGQF-UHFFFAOYSA-O 0.000 description 1
- 241000521581 Millettia Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 241001278833 Rosa laevigata Species 0.000 description 1
- 235000000661 Rosa laevigata Nutrition 0.000 description 1
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 229940046011 buccal tablet Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- MEEPUSVTMHGIPC-UHFFFAOYSA-N deoxyandrographiside Natural products OC1CCC2(C)C(CCC=3C(OCC=3)=O)C(=C)CCC2C1(C)COC1OC(CO)C(O)C(O)C1O MEEPUSVTMHGIPC-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229930184727 ginkgolide Natural products 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- BBGWVUQBIGGVLS-UHFFFAOYSA-N neoandrographolide Natural products CC1(COC2OC(CO)C(O)C(O)C2O)C(O)CCC3(C)C(CCC4=C(O)COC4=O)C(=C)CCC13 BBGWVUQBIGGVLS-UHFFFAOYSA-N 0.000 description 1
- YGCYRQKJYWQXHG-UHFFFAOYSA-N neoandrographoside Natural products C1CCC2(C)C(CCC=3C(OCC=3)=O)C(=C)CCC2C1(C)COC1OC(CO)C(O)C(O)C1O YGCYRQKJYWQXHG-UHFFFAOYSA-N 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229940023488 pill Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000013094 purity test Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101145670A CN101721530B (zh) | 2009-11-18 | 2009-11-18 | 金鸡制剂的检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101145670A CN101721530B (zh) | 2009-11-18 | 2009-11-18 | 金鸡制剂的检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101721530A CN101721530A (zh) | 2010-06-09 |
CN101721530B true CN101721530B (zh) | 2012-02-29 |
Family
ID=42443480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009101145670A Active CN101721530B (zh) | 2009-11-18 | 2009-11-18 | 金鸡制剂的检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101721530B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102226791A (zh) * | 2011-03-31 | 2011-10-26 | 宁波双伟制药有限公司 | 高效液相色谱法测定感冒清胶囊中脱水穿心莲内酯含量的方法 |
CN105403628A (zh) * | 2014-09-16 | 2016-03-16 | 广东青云山药业有限公司 | 和胃止痛胶囊中盐酸小檗碱含量的检测方法 |
CN105954457A (zh) * | 2016-06-24 | 2016-09-21 | 广西灵峰药业有限公司 | 一种金香胶囊的生产质量控制方法 |
CN106970167A (zh) * | 2017-04-28 | 2017-07-21 | 广西壮族自治区梧州食品药品检验所 | 一种测定两面针牙膏中氯化两面针碱含量的方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1733105A (zh) * | 2005-08-18 | 2006-02-15 | 贵阳云岩西创药物科技开发有限公司 | 治疗妇科疾病的金鸡制剂及制备方法和质量控制方法 |
-
2009
- 2009-11-18 CN CN2009101145670A patent/CN101721530B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1733105A (zh) * | 2005-08-18 | 2006-02-15 | 贵阳云岩西创药物科技开发有限公司 | 治疗妇科疾病的金鸡制剂及制备方法和质量控制方法 |
Non-Patent Citations (9)
Title |
---|
何开家等.长柱十大功劳中药根碱、巴马汀和小檗碱的高效液相色谱法同时测定.《分析测试学报》.2008,第27卷(第11期),第1253页仪器与试剂、色谱条件、对照品溶液的制备、供试品溶液的制备项下. * |
朱卫泉等.HPLC法测定妇科千金片中穿心莲内酯和脱水穿心莲内酯的含量.《药物分析杂志》.2006,第26卷(第06期),855-856. * |
樊晓霞等.高效液相色谱法测定复方苦参洗剂中盐酸药根碱、盐酸巴马汀和盐酸小檗碱的含量.《中国药学杂志》.2005,第40卷(第23期),1820-1822. * |
许晓峰等.HPLC法测定妇炎消洗剂中盐酸小檗碱和盐酸巴马汀的含量.《中药新药与临床药理》.2007,第18卷(第04期),320-322. * |
邢俊波等.HPLC法测定复方功劳木软胶囊中盐酸巴马汀的含量.《解放军药学学报》.2005,第21卷(第06期),461-463. * |
邢俊波等.HPLC法测定妇泰软胶囊中生物碱的含量.《中国新药杂志》.2005,第14卷(第12期),1448-1450. * |
郭炎荣等.HPLC法测定妇科千金胶囊中穿心莲内酯和脱水穿心莲内酯的含量.《中国实验方剂学杂志》.2007,第13卷(第10期),4-6. * |
陈智渊.妇科千金片穿心莲内酯含量的测定方法.《中医杂志》.2000,第41卷(第08期),482. * |
饶毅等.HPLC法同时测定双黄消炎片中黄芩苷、药根碱、巴马汀及小檗碱的含量.《药物分析杂志》.2008,第28卷(第04期),537-539. * |
Also Published As
Publication number | Publication date |
---|---|
CN101721530A (zh) | 2010-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101167788B (zh) | 一种用于久病虚损,气阴不足的贞芪扶正中药制剂质控方法 | |
CN102370921A (zh) | 强力枇杷露中药制剂的检测方法 | |
CN101884706B (zh) | 一种祛痰止咳颗粒的检测方法 | |
CN101721530B (zh) | 金鸡制剂的检测方法 | |
CN104777243B (zh) | 一种同时测定半夏中有机酸、核苷和麻黄碱的hplc方法 | |
CN102058814B (zh) | 菖蒲四味总黄酮提取物及其制备 | |
CN102879516B (zh) | 补阳还五汤的鉴别和含量测定方法 | |
CN101700262A (zh) | 穿心莲滴丸的质量控制方法 | |
CN101474249B (zh) | 益母草及其制剂的质量检测方法 | |
CN112730647A (zh) | 一种昆仙胶囊中雷公藤甲素的鉴别及含量测定方法 | |
CN101884746A (zh) | 一种治疗咳喘病的胶囊剂的检测方法 | |
CN101926889A (zh) | 芍杞颗粒剂的检测方法 | |
CN111929378B (zh) | 一种清达颗粒中天麻6种指标成分的含量测定方法 | |
CN102707006A (zh) | 穿破石配方颗粒的质量检测方法 | |
CN105616946A (zh) | 一种治疗咳嗽的制剂及其制备和质量控制方法 | |
CN109856262B (zh) | 一种可同时用于二丁制剂主要成分定性与定量分析的方法 | |
CN104345108A (zh) | 一种清肝片的定性定量检测方法 | |
CN103454374A (zh) | 骨康药物的质量控制方法 | |
CN112666278A (zh) | 华佗再造丸中士的宁的限量检测方法 | |
CN103837627A (zh) | 一种落花生茎叶药材的指纹图谱建立方法 | |
CN115219623B (zh) | 一种银杏叶颗粒中总黄酮醇苷和萜类内酯含量的测定方法 | |
CN102854282B (zh) | 一种治疗喉症的中药复方制剂的检测方法 | |
CN111830150B (zh) | 一测多评法测定新塔花中黄酮类成分含量的方法及其应用 | |
CN102335238A (zh) | 双香排石颗粒中药制剂的检测方法 | |
CN102370812A (zh) | 一种消炎退热颗粒的检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: LINGFENG PHARMACEUTICAL CO., LTD., GUANGXI Free format text: FORMER OWNER: GUANGDONG HUIKE PHARMACEUTICAL RESEARCH COMPANY LIMITED Effective date: 20131216 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Huang Yuan Inventor after: Rong Yanli Inventor after: Liang Yuezhao Inventor after: Chen Xiaojun Inventor after: Liao Zhanwei Inventor before: Huang Yuan Inventor before: Rong Yanli Inventor before: Liang Yuezhao Inventor before: Chen Xiaojun |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 530007 NANNING, GUANGXI ZHUANG AUTONOMOUS REGION TO: 542899 HEZHOU, GUANGXI ZHUANG AUTONOMOUS REGION Free format text: CORRECT: INVENTOR; FROM: HUANG YUAN RONG YANLI LIANG YUEZHAO CHEN XIAOJUN TO: HUANG YUAN RONG YANLI LIANG YUEZHAO CHEN XIAOJUN LIAO ZHANWEI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20131216 Address after: 542899 No. 68 West Anshan Road, the Guangxi Zhuang Autonomous Region, Hezhou Patentee after: Guangxi LingFeng Pharmaceutical Co.,Ltd. Address before: 530007 development center, 56 Garden Avenue, Nanning, the Guangxi Zhuang Autonomous Region Patentee before: Guangxi Huike Medicine Research Co.,Ltd. |
|
CP03 | Change of name, title or address |
Address after: No. 68, Anshan West Road, Babu District, Hezhou City, Guangxi Zhuang Autonomous Region Patentee after: Jinji Pharmaceutical Co.,Ltd. Address before: 542899 No. 68 West Anshan Road, the Guangxi Zhuang Autonomous Region, Hezhou Patentee before: Guangxi LingFeng Pharmaceutical Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200108 Address after: 535416, Lingshan Qinzhou land Industrial Park, the Guangxi Zhuang Autonomous Region Patentee after: GUANGXI GEHONGTANG PHARMACEUTICAL Co.,Ltd. Address before: No. 68, Anshan West Road, Babu District, Hezhou City, Guangxi Zhuang Autonomous Region Patentee before: Jinji Pharmaceutical Co.,Ltd. |